Case number 2017-1099
Fresenius Kabi USA, LLC v. Fera Pharmaceuticals, LLC > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Dec 18, 2017 | 67 | ORDER granting motion to terminate appeal [66] filed by Appellee Fresenius Kabi USA, LLC and Appellants Fera Pharmaceuticals, LLC and Oakwood Laboratories, LLC; issuing mandate. By: Merits Panel (Per Curiam). Service as of this date by Clerk of Court. [483298] [JAB] [Entered: 12/18/2017 12:40 PM] (2) |
| Dec 15, 2017 | 66 | MOTION of Appellants Fera Pharmaceuticals, LLC, Oakwood Laboratories, LLC and Appellee Fresenius Kabi USA, LLC to terminate appeal through joint stipulation of voluntary dismissal. [Consent: unopposed]. Service: 12/15/2017 by email. [482966] [Shashank Upadhye] [Entered: 12/15/2017 01:07 PM] (6) |
| Nov 6, 2017 | 65 | Submitted after ORAL ARGUMENT by Joseph Cwik for Fera Pharmaceuticals, LLC and Oakwood Laboratories, LLC and Imron T. Aly for Fresenius Kabi USA, LLC. Panel: Judge: Prost , Judge: Lourie , Judge: Chen. [473201] [JAB] [Entered: 11/06/2017 10:28 AM] (0) |
| Oct 12, 2017 | 64 | Response to oral argument order from the Appellants Fera Pharmaceuticals, LLC and Oakwood Laboratories, LLC. designating Joseph E. Cwik as arguing attorney. Designated time for argument: 11 minutes. Designated time for rebuttal: 4 minutes. Service of other counsel by Notice of Docket Activity from this entry. [467316] [Joseph Cwik] [Entered: 10/12/2017 11:51 AM] (0) |
| Oct 12, 2017 | 63 | Response to oral argument order from the Appellee Fresenius Kabi USA, LLC. designating Imron T. Aly as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [467214] [Jason Harp] [Entered: 10/12/2017 09:05 AM] (0) |
| Sep 21, 2017 | 62 | NOTICE OF CALENDARING. Panel: 1711A. Case scheduled Nov 06, 2017 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 201. Response to oral argument order due: 10/16/2017. Arguing counsel is required to check-in at the Clerk's Office, 4th Floor, Room 401, between 8:30 a.m. and 9:30 a.m. on the day of argument. Please review the Oral Argument Order. [462616] [JAB] [Entered: 09/21/2017 11:20 AM] (0) |
| Jul 14, 2017 | 61 | Notice from Appellee Fresenius Kabi USA, LLC regarding conflicts with oral argument (Notice pursuant to Rule 34 Practice Note re scheduling conflict for oral argument). Service: 07/14/2017 by email. [446738] [Jason Harp] [Entered: 07/14/2017 04:54 PM] (2) |
| May 9, 2017 | 60 | Notice from Appellants Fera Pharmaceuticals, LLC and Oakwood Laboratories, LLC regarding conflicts with oral argument (Appellant's counsel has no conflicts between June and September 2017). Service: 05/09/2017 by email. [430124] [Yixin Tang] [Entered: 05/09/2017 05:58 PM] (2) |
| May 9, 2017 | 59 | Statement of Compliance with Fed. Cir. R. 33 for Appellants Fera Pharmaceuticals, LLC and Oakwood Laboratories, LLC. Service: 05/09/2017 by email. [430021] [Yixin Tang] [Entered: 05/09/2017 02:40 PM] (3) |
| Apr 28, 2017 | 58 | BRIEF FILED (CD-ROM) for Appellee Fresenius Kabi USA, LLC [6 conf., 5 non-conf.]. Number of Pages: 0. Service: 04/27/2017 by US mail [427773] [SJ] [Entered: 04/28/2017 10:30 AM] (0) |
| Apr 27, 2017 | 57 | ORDER filed. The motion [44] is granted. Fresenius shall file the CD-ROM within seven days of the date of this order. Service: 04/27/2017 by clerk. [427474] [LMS] [Entered: 04/27/2017 10:39 AM] (2) |
| Apr 7, 2017 | 56 | 6 paper copies of the Corrected Confidential Joint Appendix [54] received from Appellant Fera Pharmaceuticals, LLC. [422456] [KW] [Entered: 04/07/2017 02:46 PM] (0) |
| Apr 4, 2017 | 55 | CORRECTED APPENDIX FILED for Fera Pharmaceuticals, LLC and Oakwood Laboratories, LLC [53]. Number of Pages: 450. Service: 04/04/2017 by email. Paper copies should be provided of the confidential version only. [421659] [JB] [Entered: 04/05/2017 12:27 PM] (450) |
| Apr 4, 2017 | 54 | CONFIDENTIAL JOINT APPENDIX FILED for Fera Pharmaceuticals, LLC [52]. Number of Pages: 467. Service: 04/04/2017 by email. The paper copies of the brief should be received by the court on or before 04/12/2017. [421649] [JB] [Entered: 04/05/2017 12:20 PM] (0) |
| Apr 4, 2017 | 53 | TENDERED from Appellants Fera Pharmaceuticals, LLC and Oakwood Laboratories, LLC. Title: CORRECTED JOINT APPENDIX. Service: 04/04/2017 by email. [421471] [Yixin Tang] [Entered: 04/04/2017 04:54 PM] (450) |
| Apr 4, 2017 | 52 | TENDERED from Appellants Fera Pharmaceuticals, LLC and Oakwood Laboratories, LLC. Title: CORRECTED CONFIDENTIAL JOINT APPENDIX Service: 04/04/2017 by email. [421467] [Yixin Tang] [Entered: 04/04/2017 04:44 PM] (0) |
| Mar 28, 2017 | 51 | NOTICE OF REJECTION: The brief of Appellants Fera Pharmaceuticals, LLC and Oakwood Laboratories, LLC, Joint Appendix [48], [47], is not in compliance with the rules of this court and is therefore rejected for filing (See attached notice). Corrected Appendix due 04/11/2017. Service as of this date by Clerk of Court. [419525] [JB] [Entered: 03/28/2017 01:19 PM] (2) |
| Mar 27, 2017 | 50 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellee Fresenius Kabi USA, LLC. Service: 03/27/2017 by email. [419337] [Ahmed Riaz] [Entered: 03/27/2017 09:27 PM] (4) |
| Mar 27, 2017 | 49 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants Fera Pharmaceuticals, LLC and Oakwood Laboratories, LLC. Service: 03/27/2017 by email. [419336] [Yixin Tang] [Entered: 03/27/2017 09:22 PM] (5) |
| Mar 27, 2017 | 48 | TENDERED from Appellants Fera Pharmaceuticals, LLC and Oakwood Laboratories, LLC. Title: JOINT APPENDIX. Service: 03/27/2017 by email. [419335] This brief has been rejected. See Doc No. [51] [Yixin Tang] [Entered: 03/27/2017 09:20 PM] (0) |
| Mar 27, 2017 | 47 | TENDERED from Appellants Fera Pharmaceuticals, LLC and Oakwood Laboratories, LLC. Title: CONFIDENTIAL JOINT APPENDIX Service: 03/27/2017 by email. [419334] This brief has been rejected. See Doc No. [51] [Yixin Tang] [Entered: 03/27/2017 09:18 PM] (0) |
| Mar 24, 2017 | 46 | REPLY of Appellee Fresenius Kabi USA, LLC to response filed by Appellants in 17-1099 , Doc. No [45]. Service: 03/24/2017 by email. [418849] [Imron Aly] [Entered: 03/24/2017 03:48 PM] (6) |
| Mar 24, 2017 | 45 | RESPONSE of Appellants Fera Pharmaceuticals, LLC and Oakwood Laboratories, LLC to the motion for other relief [44] filed by Appellee Fresenius Kabi USA, LLC in 17-1099. Service: 03/24/2017 by email. [418649] [Yixin Tang] [Entered: 03/24/2017 10:19 AM] (9) |
| Mar 23, 2017 | 44 | MOTION of Appellee Fresenius Kabi USA, LLC Motion for Leave to File Corresponding Briefs on CD-ROM. Any response is due within 10 days of service [Consent: opposed]. Service: 03/23/2017 by email. [418399] [Imron Aly] [Entered: 03/23/2017 02:18 PM] (6) |
| Mar 22, 2017 | 43 | 6 paper copies of the Confidential Reply Brief [41] received from Appellants Fera Pharmaceuticals, LLC and Oakwood Laboratories, LLC. [417931] [KW] [Entered: 03/22/2017 02:05 PM] (0) |
| Mar 17, 2017 | 42 | REPLY BRIEF FILED for Appellants Fera Pharmaceuticals, LLC and Oakwood Laboratories, LLC [40]. Number of Pages: 26. Service: 03/17/2017 by email. Appendix is due 03/27/2017. Paper copies should be provided of the confidential version only. [417046] [JB] [Entered: 03/20/2017 03:04 PM] (34) |
| Mar 17, 2017 | 41 | CONFIDENTIAL REPLY BRIEF FILED for Appellants Fera Pharmaceuticals, LLC and Oakwood Laboratories, LLC [39]. Number of Pages: 26. Service: 03/17/2017 by email. The paper copies of the brief should be received by the court on or before 03/27/2017. [417044] [JB] [Entered: 03/20/2017 03:02 PM] (0) |
| Mar 17, 2017 | 40 | TENDERED from Appellants Fera Pharmaceuticals, LLC and Oakwood Laboratories, LLC. Title: REPLY BRIEF. Service: 03/17/2017 by email. [416757] [Yixin Tang] [Entered: 03/17/2017 05:32 PM] (34) |
| Mar 17, 2017 | 39 | TENDERED from Appellants Fera Pharmaceuticals, LLC and Oakwood Laboratories, LLC. Title: CONFIDENTIAL REPLY BRIEF Service: 03/17/2017 by email. [416755] [Yixin Tang] [Entered: 03/17/2017 05:31 PM] (0) |
| Mar 8, 2017 | 38 | 6 paper copies of the Confidential Response Brief [35] received from Appellee Fresenius Kabi USA, LLC. [413501] [KW] [Entered: 03/08/2017 03:15 PM] (0) |
| Mar 6, 2017 | 37 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: (SECOND REMINDER) re:attorney entry of appearance Docket No. [5], ERROR: The firm contact address for Shashank Upadhye on the entry of appearance does not correspond with what we have in our database. CORRECTION: Please update your firm address and contact information with the PACER service center. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [412727] [JB] [Entered: 03/06/2017 01:14 PM] (0) |
| Mar 3, 2017 | 34 | TENDERED from Appellee Fresenius Kabi USA, LLC. Title: RESPONSE BRIEF. Service: 03/03/2017 by email. [412545] [Imron Aly] [Entered: 03/03/2017 06:15 PM] (71) |
| Mar 3, 2017 | 33 | TENDERED from Appellee Fresenius Kabi USA, LLC. Title: CONFIDENTIAL RESPONSE BRIEF Service: 03/03/2017 by email. [412544] [Imron Aly] [Entered: 03/03/2017 06:14 PM] (0) |
| Mar 3, 2017 | 35 | CONFIDENTIAL BRIEF FILED for Appellee Fresenius Kabi USA, LLC [33]. Number of Pages: 59. Service: 03/03/2017 by email. The paper copies of the brief should be received by the court on or before 03/13/2017. [412710] [JB] [Entered: 03/06/2017 12:53 PM] (0) |
| Mar 3, 2017 | 36 | BRIEF FILED for Appellee Fresenius Kabi USA, LLC [34]. Number of Pages: 59. Service: 03/03/2017 by email. Appellants Fera Pharmaceuticals, LLC and Oakwood Laboratories, LLC reply brief is due 03/17/2017. Paper copies should be provided of the confidential version only. [412724] [JB] [Entered: 03/06/2017 01:07 PM] (71) |
| Feb 16, 2017 | 32 | Corrected Entry of appearance for Christine Feller as of counsel for Appellee Fresenius Kabi USA, LLC. Service: 02/16/2017 by email. [408452] [Christine Feller] [Entered: 02/16/2017 09:33 PM] (2) |
| Feb 16, 2017 | 31 | NOTICE OF DEFICIENCY: The attorney entry of appearance Document No. [30] filed by Appellee Fresenius Kabi USA, LLC in 17-1099 is without a proper/complete proof of service and document is in an editable format and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [408340] [JB] [Entered: 02/16/2017 04:10 PM] (0) |
| Feb 16, 2017 | 30 | Entry of appearance for Christine Feller as of counsel for Appellee Fresenius Kabi USA, LLC. Service: 02/16/2017 by email. [408198] [Christine Feller] [Entered: 02/16/2017 01:19 PM] (0) |
| Jan 25, 2017 | 29 | Entry of appearance for Ahmed M.T. Riaz as of counsel for Appellee Fresenius Kabi USA, LLC. Service: 01/25/2017 by email. [401980] [Ahmed Riaz] [Entered: 01/25/2017 03:20 PM] (2) |
| Jan 18, 2017 | 28 | **TEXT ONLY** ORDER granting motion to extend time to file appellee/respondent/cross-appellant principal brief [26] filed by Appellee Fresenius Kabi USA, LLC. Appellee brief due 03/03/2017. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [399747] [JB] [Entered: 01/18/2017 08:34 AM] (0) |
| Jan 17, 2017 | 27 | Amended Entry of appearance for Thomas A. Rammer as of counsel for Appellee Fresenius Kabi USA, LLC. Service: 01/17/2017 by email. [399696] [Thomas Rammer] [Entered: 01/17/2017 04:57 PM] (2) |
| Jan 17, 2017 | 26 | MOTION of Appellee Fresenius Kabi USA, LLC to extend the time to 03/03/2017 to file the appellee/respondent/cross-appellant's principal brief. Any response is due within 10 days of service [Consent: opposed]. Service: 01/17/2017 by email. [399689] [Jason Harp] [Entered: 01/17/2017 04:49 PM] (9) |
| Dec 29, 2016 | 25 | 6 paper copies of the Confidential Opening Brief [23] received from Appellants Fera Pharmaceuticals, LLC and Oakwood Laboratories, LLC. [395186] [JCP] [Entered: 12/29/2016 04:11 PM] (0) |
| Dec 27, 2016 | 24 | BRIEF FILED for Appellants Fera Pharmaceuticals, LLC and Oakwood Laboratories, LLC [21]. Number of Pages: 45. Service: 12/23/2016 by email. The paper copies of the brief should be received by the court on or before 01/03/2017. Appellee Fresenius Kabi USA, LLC brief is due 02/01/2017. [394614] [JB] [Entered: 12/27/2016 03:29 PM] (123) |
| Dec 23, 2016 | 23 | CONFIDENTIAL BRIEF FILED for Appellants Fera Pharmaceuticals, LLC and Oakwood Laboratories, LLC [22]. Number of Pages: 45. Service: 12/23/2016 by email. The paper copies of the confidential brief should be received by the court on or before 01/03/2017. [394606] [JB] [Entered: 12/27/2016 03:21 PM] (0) |
| Dec 23, 2016 | 22 | TENDERED from Appellants Fera Pharmaceuticals, LLC and Oakwood Laboratories, LLC. Title: CONFIDENTIAL OPENING BRIEF Service: 12/23/2016 by email. [394319] [Yixin Tang] [Entered: 12/23/2016 02:41 PM] (0) |
| Dec 23, 2016 | 21 | TENDERED from Appellants Fera Pharmaceuticals, LLC and Oakwood Laboratories, LLC. Title: OPENING BRIEF. Service: 12/23/2016 by email. [394317] [Yixin Tang] [Entered: 12/23/2016 02:40 PM] (123) |
| Dec 7, 2016 | 20 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a)and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [389086] [JB] [Entered: 12/07/2016 02:33 PM] (0) |
| Nov 7, 2016 | 19 | NOTICE OF DEFICIENCY: The attorney entry of appearance for Thomas A. Rammer Document No. [18] filed by Appellee Fresenius Kabi USA, LLC cannot be accepted for filing at this time. The firm, email and contact information provided in your entry of appearance does not match our database. Please update your contact and firm information via the PACER service center. [380906] [JB] [Entered: 11/07/2016 02:16 PM] (0) |
| Nov 7, 2016 | 18 | Entry of appearance for Thomas A. Rammer as of counsel for Appellee Fresenius Kabi USA, LLC. Service: 11/07/2016 by email. [380880] [Thomas Rammer] [Entered: 11/07/2016 01:46 PM] (2) |
| Nov 7, 2016 | 17 | Entry of appearance for Stephen J. Smith as of counsel for. Service: 11/07/2016 by email. [380874] [Stephen Smith] [Entered: 11/07/2016 01:43 PM] (2) |
| Nov 7, 2016 | 16 | Entry of appearance for Jason G. Harp as of counsel for Appellee Fresenius Kabi USA, LLC. Service: 11/07/2016 by email. [380871] [Jason Harp] [Entered: 11/07/2016 01:40 PM] (2) |
| Nov 7, 2016 | 15 | Entry of appearance for John K. Hsu as of counsel for Appellee Fresenius Kabi USA, LLC. Service: 11/07/2016 by email. [380869] [John Hsu] [Entered: 11/07/2016 01:36 PM] (2) |
| Nov 4, 2016 | 14 | Certificate of Interest for the Appellee Fresenius Kabi USA, LLC. Service: 11/04/2016 by email. [380590] [Imron Aly] [Entered: 11/04/2016 04:09 PM] (2) |
| Nov 4, 2016 | 13 | Docketing Statement for the Appellee Fresenius Kabi USA, LLC. Service: 11/04/2016 by email. [380588] [Imron Aly] [Entered: 11/04/2016 04:08 PM] (4) |
| Nov 4, 2016 | 12 | Entry of appearance for Imron T. Aly as principal counsel for Appellee Fresenius Kabi USA, LLC. Service: 11/04/2016 by email. [380587] [Imron Aly] [Entered: 11/04/2016 04:00 PM] (2) |
| Nov 3, 2016 | 11 | Entry of appearance for Adam D. Sussman as of counsel for Appellants Fera Pharmaceuticals, LLC and Oakwood Laboratories, LLC. Service: 11/03/2016 by email. [380254] [Yixin Tang] [Entered: 11/03/2016 05:38 PM] (2) |
| Oct 31, 2016 | 10 | Docketing Statement for the Appellants Fera Pharmaceuticals, LLC and Oakwood Laboratories, LLC. Service: 10/31/2016 by email. [378851] [Yixin Tang] [Entered: 10/31/2016 02:08 PM] (3) |
| Oct 28, 2016 | 9 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance Docket No. [5], attorney entry of appearance Docket No. [4], ERROR: The firm contact information on the entry of appearance does not correspond with what we have in our database. CORRECTION: Please update your firm name and contact information with the PACER service center. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [378283] [JB] [Entered: 10/28/2016 10:41 AM] (0) |
| Oct 28, 2016 | 8 | Copy of Corrected Opinion and Order from United States District Court for the District of New Jersey DE333. [378242] [JB] [Entered: 10/28/2016 09:24 AM] (28) |
| Oct 27, 2016 | 7 | Transcript Purchase Order Form for the Appellants Fera Pharmaceuticals, LLC and Oakwood Laboratories, LLC indicating that a transcript is already on file. Service: 10/27/2016 by email. [378128] [Yixin Tang] [Entered: 10/27/2016 03:32 PM] (2) |
| Oct 27, 2016 | 6 | Certificate of Interest for the Appellants Fera Pharmaceuticals, LLC and Oakwood Laboratories, LLC. Service: 10/27/2016 by email. [378126] [Yixin Tang] [Entered: 10/27/2016 03:32 PM] (2) |
| Oct 27, 2016 | 5 | Entry of appearance for Shashank Upadhye as of counsel for Appellants Fera Pharmaceuticals, LLC and Oakwood Laboratories, LLC. Service: 10/27/2016 by email. [378125] [Yixin Tang] [Entered: 10/27/2016 03:31 PM] (2) |
| Oct 27, 2016 | 4 | Entry of appearance for Joseph E. Cwik as of counsel for Appellants Fera Pharmaceuticals, LLC and Oakwood Laboratories, LLC. Service: 10/27/2016 by email. [378123] [Yixin Tang] [Entered: 10/27/2016 03:30 PM] (2) |
| Oct 27, 2016 | 3 | Entry of appearance for Erin R. Conway as of counsel for Appellants Fera Pharmaceuticals, LLC and Oakwood Laboratories, LLC. Service: 10/27/2016 by email. [378122] [Yixin Tang] [Entered: 10/27/2016 03:30 PM] (2) |
| Oct 27, 2016 | 2 | Entry of appearance for Yixin H. Tang as principal counsel for Appellants Fera Pharmaceuticals, LLC and Oakwood Laboratories, LLC. Service: 10/27/2016 by email. [378119] [Yixin Tang] [Entered: 10/27/2016 03:29 PM] (2) |
| Oct 24, 2016 | 1 | Appeal docketed. Received: 10/21/2016. [377195]Entry of Appearance due 11/07/2016. Certificate of Interest is due on 11/07/2016. Docketing Statement due 11/07/2016. Appellant/Petitioner's brief is due 12/23/2016. [JB] [Entered: 10/24/2016 03:57 PM] (62) |
